Results 261 to 270 of about 2,398,894 (298)

New Senolysis Approach via Antibody–Drug Conjugate Targeting of the Senescent Cell Marker Apolipoprotein D for Skin Rejuvenation

International Journal of Molecular Sciences, 2023
Kento Takaya, Kazuo Kishi
exaly  

Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy

Expert Opinion on Biological Therapy, 2020
Robert Sharkey, David M Goldenberg
exaly  

Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review

Cancers, 2021
Vito Carlo Alberto Caponio, Emily Capone, Vittoria Perrotti   +2 more
exaly  

Antibody drug conjugates

2022
XU HE, LEE HONG MYUNG, ARENDT CHRISTOPHER   +2 more
openaire   +5 more sources

What makes a good antibody–drug conjugate?

Expert Opinion on Biological Therapy, 2021
exaly  

Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours

Cancers, 2022
Linda Hii, Simon Wilkins, Mary Vail
exaly  

Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody–Drug Conjugate

Molecules, 2020
Byeongill Lee, Young Shin, Yun-Hee Park   +2 more
exaly  

The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1

Cancers, 2020
Santiago Escrivà de Romaní, Cristina Saura Manich, Joaquin Arribas   +2 more
exaly  

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer

Annals of Oncology, 2016
Yulei Wang, J R Infante, M J Birrer
exaly  

The antibody–drug conjugate target landscape across a broad range of tumour types

Annals of Oncology, 2017
Rudolf S N Fehrmann, E G E de Vries
exaly